Tomorrow edition interviews Peter Schmidt, Ph.D., is Senior Vice President, Chief Research & Clinical Officer, at the Parkinson’s Foundation. Dr. Schmidt discusses selective vulnerability in PD, replicating the disease in a lab and discusses PD clinical trial processes.
Tomorrow Edition: Interview With Clinical Trial Expert Dr. Peter Schmidt
An analysis found that people with PD are no more likely to report being in a crash but are more likely to fail simulator driving tests or on-road driving assessments. Senior study author Ergun Y. Uc, MD, is the director of the Division of Movement Disorders at the University of Iowa, a Center of Excellence.
Three centers have been added to the Centers of Excellence network, increasing the number of Parkinson’s Foundation centers to 45. John Lehr, Parkinson’s Foundation CEO and President is quoted throughout.
The Parkinson's Foundation is hosting Moving Day Rochester October 7. An annual event helping raise money and awareness for the fight against Parkinson's.
Dr. Robert Hauser from the University of South Florida, a Parkinson’s Foundation Center of Excellence, writes about the “golden year” for people with Parkinson’s (the first 6 to 12 months following a diagnosis) and the importance of enrolling in a clinical trial during this time.
The FDA issued a review on the drug NUPLAZID (pimavanserin), a medication used to treat patients with PD associated psychosis. The FDA did not identify any new or unexpected safety findings. Dr. Michael S. Okun, Parkinson’s Foundation national medical director, is quoted.
The model, musician and long-distance runner Rudy Aldridge talks about becoming a Parkinson’s Champion and running for a cause. Rudy’s father passed from PD complications in 2017.
A University of Miami, a Center of Excellence, study is using video game technology to help physicians more accurately diagnose PD. The latest phase of the project is aided by funds from the Provost's Office and a Parkinson’s Foundation grant.
The benefits of exercise for those with PD have been supported by research and can help people manage their PD symptoms. Parkinson’s Outcome Project study findings are mentioned.
A team of researchers at Israel’s Technion Institute of Technology has developed a device they say can detect the early onset of Parkinson’s disease by analyzing the breath of users. Parkinson’s Foundation quoted for statistics.
Dan Davis, from Parkinson’s Foundation Ohio, interviewed about Moving Day Columbus. Moving Day is an inspiring walk uniting families, friends and communities in the effort to raise awareness and research funds.